DR. MIELKE: Dr. Davis, would you please open this morning's discussion by commenting on the person who is infected with HIV but escapes present-day screening techniques: the so-called "window" period. DR. DAVIS: This so-called "window" period that you refer to has only been found in a very small pe
โฆ LIBER โฆ
Panel discussion: Session 3
โ Scribed by C. H. Mielke Jr.; Steven Meltzer; Bruce Evatt; Ann C. Collier; William E. Lafferty; Mimi Fields
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 650 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0733-2459
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Panel discussion: Session 1
โ
C. H. Mielke Jr.; Jean-Pierre Allain; Brian R. Davis; Jay A. Levy
๐
Article
๐
1993
๐
John Wiley and Sons
๐
English
โ 740 KB
Panel discussion: Session 2
โ
C. H. Mielke Jr.; George W. Schneider Jr.; Herbert A. Perkins; David L. Aronson;
๐
Article
๐
1993
๐
John Wiley and Sons
๐
English
โ 595 KB
Panel discussions with the chairmen of t
๐
Article
๐
1982
๐
Elsevier Science
๐
English
โ 650 KB
Panel discussion and open forum (closing
โ
L. B. Felsen
๐
Article
๐
1992
๐
John Wiley and Sons
๐
English
โ 341 KB
Panel discussion
๐
Article
๐
1994
๐
John Wiley and Sons
๐
English
โ 602 KB
## Panel Discussion Question: Would you say that the safety of the newer antidepressant drugs in overdose outweighs the advanlages of the tricyclic antidepressants ( TCAs), which are basedon the test of time andgeneralknowledge? Should the TCAs now be drugs of second choice or should they remain d
Panel Discussion
๐
Article
๐
1978
๐
Elsevier Science
๐
English
โ 575 KB